DE:9SO Stock Latest News
Company AnnouncementsSolasia Pharma Advances Oncology Portfolio With Partner Shifts and Global Expansion2M ago
Company AnnouncementsSolasia Pharma Widens Mid-Year Loss and Scraps Full-Year Forecast Amid Revenue Slump2M ago
Company AnnouncementsSolasia Pharma advances oncology pipeline, expands global reach for key cancer drugs5M ago
Company AnnouncementsSolasia Pharma Posts Wider Quarterly Loss and Withholds 2026 Guidance5M ago
Company AnnouncementsSolasia Pharma Advances Oncology Pipeline and Expands Global Reach for Key Cancer Drugs8M ago
Company AnnouncementsSolasia Pharma Narrows Losses on Higher Sales but Withholds 2026 Outlook8M agoCompany AnnouncementsSolasia Pharma Advances Oncology Pipeline and Expands Global Reach for Key Cancer Drugs8M ago
Company AnnouncementsSolasia Grants MAAB Exclusive China Rights to Sancuso in Sales Framework Overhaul9M ago
Company AnnouncementsSolasia Pharma Cuts FY2025 Sales Outlook on China Delays and License Changes10M ago
Company AnnouncementsSolasia Pharma Expands Global Reach with Strategic Partnerships11M ago
Company AnnouncementsSolasia Pharma Reports Nine-Month Financial Results with Sales Growth Amidst Challenges11M ago
Company AnnouncementsSolasia Pharma Reports Q2 Financials and Pipeline Progress1y agoCompany AnnouncementsSolasia Pharma Reports First Half 2025 Financial Results Amid Ongoing Challenges1y ago
Company AnnouncementsSolasia Pharma Reports Q1 Results and Pipeline Updates1y ago
Company AnnouncementsSolasia Pharma Reports Q1 2025 Financial Results with Increased Sales but Continued Losses1y ago
Company AnnouncementsSolasia Pharma Resumes SP-05 Development with New Fundraising1y ago
Company AnnouncementsSolasia Pharma Announces Capital Reduction and Financial Adjustments1y ago
Company AnnouncementsSolasia Pharma Reports Impairment Loss and Earnings Shortfall for 20241y ago

